NCT03792841 2025-10-16Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPCAmgenPhase 1 Terminated212 enrolled
NCT04631601 2025-10-07Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)AmgenPhase 1/2 Terminated65 enrolled
NCT04609579 2024-01-30Study of SNX281 in Subjects With Advanced Solid Tumors and LymphomaStingthera, Inc.Phase 1 Terminated27 enrolled